Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients
Clinical trial NCT04524351 · COMPLETED
Trial details
- NCT number
- NCT04524351
- Sponsor
- Annovis Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-14
- Primary completion
- 2021-08-16
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.